Deep brain stimulation for Parkinson disease in Australia: Current scientific and clinical status

P. C. Poortvliet, Peter A. Silburn, T. J. Coyne, H. J. Chenery

Research output: Contribution to journalArticleResearchpeer-review

10 Citations (Scopus)

Abstract

There is currently no cure for Parkinson disease (PD). Disease management is directed primarily at motor symptom relief, but the impact of non-motor symptoms associated with PD should not be underestimated. Medical and surgical treatment options aim to increase functional independence and quality of life. Deep brain stimulation (DBS) has proven to be a safe, effective and cost-efficient surgical treatment option. In 2009, the Australian referral guidelines, developed to provide a synopsis of DBS therapy for PD, were introduced, and since then novel findings have been reported regarding the timing of intervention, target selection and symptom management. Our aim is to provide an update of DBS for PD in Australia. Intervention at earlier stages of the disease can potentially improve quality of life over a longer period with greater possibilities for meaningful social and professional contributions. For less responsive motor symptoms (e.g. freezing of gait, postural instability), the pedunculopontine nucleus has emerged as a promising new surgical target. Traditional PD treatment is focused on improvement of motor symptoms, but the disorder is also characterised by non-motor symptoms, often undiagnosed or undisclosed, that have the potential to impact quality of life to a greater extent than motor symptoms. It is essential to identify and routinely monitor for non-motor symptoms as they can emerge at all stages of the disease or can result from treatment. Many of these current advances require long-term monitoring of treatment outcomes to improve future clinical practice, refine patient selection and ensure best patient outcomes.

Original languageEnglish
Pages (from-to)134-139
Number of pages6
JournalInternal Medicine Journal
Volume45
Issue number2
DOIs
Publication statusPublished - 1 Feb 2015
Externally publishedYes

Fingerprint

Deep Brain Stimulation
Parkinson Disease
Quality of Life
Therapeutics
Disease Management
Gait
Patient Selection
Freezing
Referral and Consultation
Guidelines
Costs and Cost Analysis

Cite this

Poortvliet, P. C. ; Silburn, Peter A. ; Coyne, T. J. ; Chenery, H. J. / Deep brain stimulation for Parkinson disease in Australia : Current scientific and clinical status. In: Internal Medicine Journal. 2015 ; Vol. 45, No. 2. pp. 134-139.
@article{209e98be16794e3bb76e8f12705531b1,
title = "Deep brain stimulation for Parkinson disease in Australia: Current scientific and clinical status",
abstract = "There is currently no cure for Parkinson disease (PD). Disease management is directed primarily at motor symptom relief, but the impact of non-motor symptoms associated with PD should not be underestimated. Medical and surgical treatment options aim to increase functional independence and quality of life. Deep brain stimulation (DBS) has proven to be a safe, effective and cost-efficient surgical treatment option. In 2009, the Australian referral guidelines, developed to provide a synopsis of DBS therapy for PD, were introduced, and since then novel findings have been reported regarding the timing of intervention, target selection and symptom management. Our aim is to provide an update of DBS for PD in Australia. Intervention at earlier stages of the disease can potentially improve quality of life over a longer period with greater possibilities for meaningful social and professional contributions. For less responsive motor symptoms (e.g. freezing of gait, postural instability), the pedunculopontine nucleus has emerged as a promising new surgical target. Traditional PD treatment is focused on improvement of motor symptoms, but the disorder is also characterised by non-motor symptoms, often undiagnosed or undisclosed, that have the potential to impact quality of life to a greater extent than motor symptoms. It is essential to identify and routinely monitor for non-motor symptoms as they can emerge at all stages of the disease or can result from treatment. Many of these current advances require long-term monitoring of treatment outcomes to improve future clinical practice, refine patient selection and ensure best patient outcomes.",
author = "Poortvliet, {P. C.} and Silburn, {Peter A.} and Coyne, {T. J.} and Chenery, {H. J.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1111/imj.12656",
language = "English",
volume = "45",
pages = "134--139",
journal = "Australian and New Zealand Journal of Medicine",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "2",

}

Deep brain stimulation for Parkinson disease in Australia : Current scientific and clinical status. / Poortvliet, P. C.; Silburn, Peter A.; Coyne, T. J.; Chenery, H. J.

In: Internal Medicine Journal, Vol. 45, No. 2, 01.02.2015, p. 134-139.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Deep brain stimulation for Parkinson disease in Australia

T2 - Current scientific and clinical status

AU - Poortvliet, P. C.

AU - Silburn, Peter A.

AU - Coyne, T. J.

AU - Chenery, H. J.

PY - 2015/2/1

Y1 - 2015/2/1

N2 - There is currently no cure for Parkinson disease (PD). Disease management is directed primarily at motor symptom relief, but the impact of non-motor symptoms associated with PD should not be underestimated. Medical and surgical treatment options aim to increase functional independence and quality of life. Deep brain stimulation (DBS) has proven to be a safe, effective and cost-efficient surgical treatment option. In 2009, the Australian referral guidelines, developed to provide a synopsis of DBS therapy for PD, were introduced, and since then novel findings have been reported regarding the timing of intervention, target selection and symptom management. Our aim is to provide an update of DBS for PD in Australia. Intervention at earlier stages of the disease can potentially improve quality of life over a longer period with greater possibilities for meaningful social and professional contributions. For less responsive motor symptoms (e.g. freezing of gait, postural instability), the pedunculopontine nucleus has emerged as a promising new surgical target. Traditional PD treatment is focused on improvement of motor symptoms, but the disorder is also characterised by non-motor symptoms, often undiagnosed or undisclosed, that have the potential to impact quality of life to a greater extent than motor symptoms. It is essential to identify and routinely monitor for non-motor symptoms as they can emerge at all stages of the disease or can result from treatment. Many of these current advances require long-term monitoring of treatment outcomes to improve future clinical practice, refine patient selection and ensure best patient outcomes.

AB - There is currently no cure for Parkinson disease (PD). Disease management is directed primarily at motor symptom relief, but the impact of non-motor symptoms associated with PD should not be underestimated. Medical and surgical treatment options aim to increase functional independence and quality of life. Deep brain stimulation (DBS) has proven to be a safe, effective and cost-efficient surgical treatment option. In 2009, the Australian referral guidelines, developed to provide a synopsis of DBS therapy for PD, were introduced, and since then novel findings have been reported regarding the timing of intervention, target selection and symptom management. Our aim is to provide an update of DBS for PD in Australia. Intervention at earlier stages of the disease can potentially improve quality of life over a longer period with greater possibilities for meaningful social and professional contributions. For less responsive motor symptoms (e.g. freezing of gait, postural instability), the pedunculopontine nucleus has emerged as a promising new surgical target. Traditional PD treatment is focused on improvement of motor symptoms, but the disorder is also characterised by non-motor symptoms, often undiagnosed or undisclosed, that have the potential to impact quality of life to a greater extent than motor symptoms. It is essential to identify and routinely monitor for non-motor symptoms as they can emerge at all stages of the disease or can result from treatment. Many of these current advances require long-term monitoring of treatment outcomes to improve future clinical practice, refine patient selection and ensure best patient outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84964284204&partnerID=8YFLogxK

U2 - 10.1111/imj.12656

DO - 10.1111/imj.12656

M3 - Article

VL - 45

SP - 134

EP - 139

JO - Australian and New Zealand Journal of Medicine

JF - Australian and New Zealand Journal of Medicine

SN - 1444-0903

IS - 2

ER -